JAZZ News and Press, Jazz Pharmaceuticals plc From 11/30/21

Jazz Pharmaceuticals Announces First Patient Enrolled in IMforte Phase 3 Trial Evaluating Zepzelca® (lurbinectedin) in Combination with a PD-L1 Inhibitor in Small Cell Lung Cancer Registrational trial will assess the potential for a novel combination therapy in extensive-st...

Jazz Pharmaceuticals Announces Commercial Availability in Canada of Zepzelca™ (lurbinectedin), the First New Treatment for Stage III or Metastatic Small Cell Lung Cancer in More Than a Decade Canada NewsWire DUBLIN , Nov. 30, 2021 /CNW/ - Jazz Pharmaceutic...

Exchange traded funds can play a valuable role for many cannabis investors. Three years after legalization in Canada, there is now enough data to evaluate cannabis ETF performance. The AdvisorShares Pure Cannabis ETF has been a superior performer in both good and bad markets. ...

With Republicans in the House of Representatives recently introducing legislation to legalize marijuana at the federal level , the potential for a bipartisan framework is as close as it's ever been. While the patchwork quilt of state-by-state efforts is a workaround of sorts for a growi...

Investing in the cannabis industry for the long haul can be a decision that you thank yourself for later on. The simple reason is that there is significant growth potential there. According to marijuana research company BDSA, the global cannabis market will be worth more than $62 billion by...

Investing In The Cannabis Sector In 2021 Are you looking for the best marijuana stocks to buy next week? Since November 5 th we have seen the top cannabis stocks to invest in begin to rally around Republican-drafted legislation for federal marijuana legalization and reform. The ...

After the market closed on Tuesday, Jazz Pharmaceuticals plc (Nasdaq: JAZZ) released its financial results for the third quarter of 2021 and updated financial guidance for 2021. Total revenues for Jazz increased 39% to $838.1 million versus last year’s third quarter...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips There are plenty of opportunities as the market heads higher. But despite the positive direction, there are still plenty of stocks to sell. First, let’s take a look at some of the positives. Unemployment numbers ar...

Image source: The Motley Fool. Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) Q3 2021 Earnings Call Nov 9, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Jazz Pharmaceuticals PLC (JAZZ) Q3 2021 Earnings Call Transcript

Jazz Pharmaceuticals PLC (JAZZ) Q3 2021 Earnings Conference Call November 09, 2021, 16:30 ET Company Participants Andrea Flynn - VP & Head, IR Bruce Cozadd - Co-Founder, Chairman & CEO Daniel Swisher - President Robert Iannone - EVP, Research & Development & Chief Medical Offi...